Page last updated: 2024-08-24

goralatide and Esophageal Neoplasms

goralatide has been researched along with Esophageal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cappelaere, P; Carde, P; Chauvergne, J; De Gislain, C; Domenge, C; Dufour-Esquerré, F; Hecquet, B; Krakowski, I; Meeus, L; Rolland, F	1

Trials

1 trial(s) available for goralatide and Esophageal Neoplasms

Article	Year
[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination]. Bulletin du cancer, 1995, Volume: 82, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorouracil; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Oligopeptides; Placebos	1995

Article

Year

[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination].

Bulletin du cancer, 1995, Volume: 82, Issue:9

Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorouracil; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Oligopeptides; Placebos

1995